Paul Richardson

发表

Local biases drive, but do not determine, the perception of illusory trajectories

Tamara N. Gheorghes, Paul Richardson, John Reidy, 2020, Scientific Reports.

Kinetically guided radical-based synthesis of C(sp3)−C(sp3) linkages on DNA

Jie Wang, Stephen Brown, William Farrell, 2018, Proceedings of the National Academy of Sciences.

Targeting p38 MAPK inhibits multiple myeloma cell growth in the bone marrow milieu.

Masaharu Akiyama, Paul Richardson, Toshiaki Hayashi, 2003, Blood.

Targeting the Phosphatidylinositol 3-Kinase Pathway in Multiple Myeloma

Paul Richardson, Anne-Sophie Moreau, K. Anderson, 2007, Clinical Cancer Research.

Vaccination with Dendritic Cell/Tumor Fusions following Autologous Stem Cell Transplant Induces Immunologic and Clinical Responses in Multiple Myeloma Patients

Nikhil C. Munshi, Edie Weller, Kenneth Anderson, 2013, Clinical Cancer Research.

A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib.

Hiroshi Yasui, Paul Richardson, Benjamin Nicholson, 2005, Cancer cell.

Thalidomide for patients with relapsed multiple myeloma after high-dose chemotherapy and stem cell transplantation: results of an open-label multicenter phase 2 study of efficacy, toxicity, and biological activity.

Faith Davies, Edie Weller, Kenneth Anderson, 2004, Mayo Clinic proceedings.

Long Intergenic Non-Coding RNAs have an Independent Impact on Survival in Multiple Myeloma

Giovanni Parmigiani, Daniel Auclair, Kenneth C. Anderson, 2018, Leukemia.

Combination of the mTOR inhibitor rapamycin and CC-5013 has synergistic activity in multiple myeloma.

Paul Richardson, N. Munshi, P. Richardson, 2004, Blood.

Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib.

Anthony Boral, Paul Richardson, Yongsheng Huang, 2006, Blood.

Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma.

Jessica Katz, Hermann Einsele, Paul Richardson, 2015, The New England journal of medicine.

A novel Aurora-A kinase inhibitor MLN8237 induces cytotoxicity and cell-cycle arrest in multiple myeloma.

Jeffrey Ecsedy, Loredana Santo, Paul Richardson, 2009, Blood.

International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.

Hans Erik Johnsen, Giampaolo Merlini, Robert A Kyle, 2014, The Lancet. Oncology.

Prospective Evaluation of Magnetic Resonance Imaging and [18F]Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography at Diagnosis and Before Maintenance Therapy in Symptomatic Patients With Multiple Myeloma Included in the IFM/DFCI 2009 Trial: Results of the IMAJEM Study.

Jean-Michel Nguyen, Caroline Bodet-Milin, Kenneth Anderson, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.